Mork Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-15,000
| Closed | -$1.67M | – | 119 |
|
|
2025
Q3 | $1.67M | Hold |
15,000
| – | – | 1.15% | 28 |
|
|
2025
Q2 | $1.66M | Hold |
15,000
| – | – | 1.21% | 22 |
|
|
2025
Q1 | $1.68M | Hold |
15,000
| – | – | 1.32% | 17 |
|
|
2024
Q4 | $1.39M | Hold |
15,000
| – | – | 0.91% | 35 |
|
|
2024
Q3 | $1.26M | Hold |
15,000
| – | – | 0.9% | 41 |
|
|
2024
Q2 | $1.03M | Hold |
15,000
| – | – | 0.81% | 62 |
|
|
2024
Q1 | $1.1M | Hold |
15,000
| – | – | 0.83% | 51 |
|
|
2023
Q4 | $1.22M | Hold |
15,000
| – | – | 0.75% | 44 |
|
|
2023
Q3 | $1.12M | Hold |
15,000
| – | – | 0.88% | 35 |
|
|
2023
Q2 | $1.16M | Hold |
15,000
| – | – | 0.89% | 35 |
|
|
2023
Q1 | $1.24M | Hold |
15,000
| – | – | 1.01% | 29 |
|
|
2022
Q4 | $1.29M | Hold |
15,000
| – | – | 0.99% | 29 |
|
|
2022
Q3 | $925K | Hold |
15,000
| – | – | 0.91% | 43 |
|
|
2022
Q2 | $927K | Hold |
15,000
| – | – | 0.85% | 56 |
|
|
2022
Q1 | $892K | Hold |
15,000
| – | – | 0.8% | 79 |
|
|
2021
Q4 | $1.09M | Hold |
15,000
| – | – | 0.74% | 57 |
|
|
2021
Q3 | $1.05M | Hold |
15,000
| – | – | 0.89% | 60 |
|
|
2021
Q2 | $1.03M | Hold |
15,000
| – | – | 0.75% | 77 |
|
|
2021
Q1 | $969K | Hold |
15,000
| – | – | 0.74% | 81 |
|
|
2020
Q4 | $874K | Hold |
15,000
| – | – | 0.64% | 92 |
|
|
2020
Q3 | $948K | Hold |
15,000
| – | – | 1.04% | 41 |
|
|
2020
Q2 | $1.15M | Hold |
15,000
| – | – | 1.36% | 20 |
|
|
2020
Q1 | $1.12M | Hold |
15,000
| – | – | 1.54% | 11 |
|
|
2019
Q4 | $975K | Hold |
15,000
| – | – | 0.7% | 95 |
|
|
2019
Q3 | $951K | Hold |
15,000
| – | – | 0.87% | 52 |
|
|
2019
Q2 | $1.01M | Hold |
15,000
| – | – | 0.94% | 40 |
|
|
2019
Q1 | $975K | Hold |
15,000
| – | – | 0.91% | 41 |
|
|
2018
Q4 | $938K | Hold |
15,000
| – | – | 0.88% | 41 |
|
|
2018
Q3 | $1.16M | Hold |
15,000
| – | – | 0.93% | 45 |
|
|
2018
Q2 | $1.06M | Hold |
15,000
| – | – | 0.94% | 47 |
|
|
2018
Q1 | $1.13M | Hold |
15,000
| – | – | 1.08% | 33 |
|
|
2017
Q4 | $1.07M | Hold |
15,000
| – | – | 0.72% | 49 |
|
|
2017
Q3 | $1.22M | Hold |
15,000
| – | – | 0.98% | 29 |
|
|
2017
Q2 | $1.06M | Hold |
15,000
| – | – | 0.91% | 34 |
|
|
2017
Q1 | $1.02M | Buy |
+15,000
| New | +$1.05M | 0.91% | 33 |
|
Other funds holding GILD
Mork Capital Management's GILD Position: Q4 2025 in Review
Mork Capital Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 15,000 shares — an estimated $1.67M sold.
Mork Capital Management first reported a position in GILD in Q1 2017 and held it in 35 quarters. The position peaked at $1.68M in Q1 2025. 2,221 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Mork Capital Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- Mork Capital Management sold 15,000 Gilead Sciences shares in Q4 2025, an estimated $1.67M.
- Mork Capital Management first reported a position in Gilead Sciences in Q1 2017 and held it in 35 quarters.
- Mork Capital Management's Gilead Sciences position peaked at $1.68M in Q1 2025.
- 2,221 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Mork Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.